These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20962655)

  • 1. Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy.
    Weber CF; Görlinger K; Byhahn C; Moritz A; Hanke AA; Zacharowski K; Meininger D
    Eur J Anaesthesiol; 2011 Jan; 28(1):57-62. PubMed ID: 20962655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic Acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up.
    Shi J; Wang G; Lv H; Yuan S; Wang Y; Ji H; Li L
    Ann Thorac Surg; 2013 Mar; 95(3):795-802. PubMed ID: 22959576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antiplatelet therapy in ACS: time-dependent variability in platelet aggregation during the first week.
    Guha S; Sardar P; Guha P; Deb S; Karmakar R; Chakraborti P; Mookerjee S; Deb PK; De R; Dutta A; Chaudhuri U
    Indian Heart J; 2009; 61(2):173-7. PubMed ID: 20039503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
    Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
    Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
    Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial.
    Shi J; Ji H; Ren F; Wang G; Xu M; Xue Y; Chen M; Qi J; Li L
    JAMA Surg; 2013 Jun; 148(6):538-47. PubMed ID: 23426385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To adjust or not to adjust the platelet count in light transmission aggregometry in patients receiving dual aspirin/clopidogrel treatment.
    van der Stelt CA; van Werkum JW; Seesing TH; Berg JM; Hackeng CM
    Platelets; 2007 Nov; 18(7):550-3. PubMed ID: 17957573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balancing thrombotic and bleeding risks related to antiplatelet therapy in coronary bypass surgery: Comment on "Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting".
    Faraday N
    JAMA Surg; 2013 Jun; 148(6):548. PubMed ID: 23426400
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract]   [Full Text] [Related]  

  • 12. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
    Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
    Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
    Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
    Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiplatelet effects of combined therapy with ticlopidine and low doses of aspirin on patients with ischemic cardiopathy].
    Davì G; Catalano I; Spatola A; Alaimo P; Notarbartolo A; Cerbone AM; Strano A
    Cardiologia; 1989 Jan; 34(1):69-71. PubMed ID: 2720715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
    Angiolillo DJ; Bernardo E; Capodanno D; Vivas D; Sabaté M; Ferreiro JL; Ueno M; Jimenez-Quevedo P; Alfonso F; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2010 Mar; 55(11):1139-46. PubMed ID: 20223369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of platelet aggregation and fibrinogen levels to advancing age in aspirin- and thienopyridine-treated patients.
    Koltai K; Feher G; Kenyeres P; Lenart I; Alexy T; Horvath B; Marton Z; Kesmarky G; Toth K
    Clin Hemorheol Microcirc; 2008; 40(4):295-302. PubMed ID: 19126992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement].
    Toyohira H; Nakamura K; Kariyazono H; Yamada K; Moriyama Y; Shimokawa S; Saigenji H; Taira A
    Kyobu Geka; 1995 Aug; 48(9):749-55. PubMed ID: 7564036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to aspirin and clopidogrel monitored with different platelet function methods.
    Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
    Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome.
    Cuisset T; Hamilos M; Delrue M; Frère C; Verhamme K; Bartunek J; Saut N; Bonnet JL; Eijgelsheim M; Wijns W; Alessi MC; Barbato E
    Thromb Haemost; 2010 Apr; 103(4):774-9. PubMed ID: 20135061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.